The future sponsorship of CME in Canada: Industry, government, physicians or a blend?

CMAJ. Canadian Medical Association Journal

Volumn 171, Issue 2, 2004, Pages 150-151

  Marlow, Bernard ^a  

^a Coll of Family Physicians of Canada ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CONTINUING EDUCATION; DRUG INDUSTRY; EDUCATION PROGRAM; FINANCIAL MANAGEMENT; MEDICAL EDUCATION; NOTE; CANADA; ECONOMICS; GOVERNMENT; ORGANIZATION AND MANAGEMENT; PHYSICIAN ATTITUDE; STANDARD;

CANADA; DRUG INDUSTRY; EDUCATION, MEDICAL, CONTINUING; FINANCIAL MANAGEMENT; GOVERNMENT; PHYSICIAN'S ROLE;

EID: 3442878968     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: 10.1503/cmaj.1040629     Document Type: Note

References (7)

1. What's wrong with CME? [editorial]. CMAJ 2004;170(6):917.
2. Wolfe SM. Why do American drug companies spend more than $12 billion a year pushing drugs? Is it education or promotion? J Gen Intern Med 1996;11:637-9.
3. Wazana A. Physicians and the pharmaceutical industry. Is a gift ever just a gift? JAMA 2000;283:373-80.
4. Bowman MA. The impact of drug company funding on the content of continuing medical education. Mobius 1986;6:66-9.
5. Bowman MA, Pearle DL. Changes in drug prescribing patterns related to commercial company funding of continuing medical education. J Contin Educ Health Prof 1988;8:13-20.
6. Relman AS. Defending professional independence: ACCME's proposed new guidelines for commercial support of CME. JAMA 2003;289(18):2418-20.
7. Van Harrison R. The uncertain future of continuing medical education: commercialism and shifts in funding. J Contin Educ Health Prof 2003;23(4):198-209.